NL-OMON24114招募中不适用
Response and markers of response in chronic hepatitis B patients treated with Peg-interferon alfa-2a and adefovir.
Roche PahrmaceuticalsGiliad UCB0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Male and female patients > 18 years of age;
- •2. Positive HBsAg for more than 6 months;
排除标准
- •1. Patients co-infected with HCV, HDV, HIV or who have decompensated liver disease, hepato-cellular carcinoma, pre-existing severe depression or other psychiatric disease, significant cardiac disease, significant renal disease, seizure disorders or severe retinopathy will be excluded;
- •2. Patients who have received LAM therapy for their chronic hepatitis B within 6 weeks before enrollment or any other antiviral therapy for their chronic hepatitis B within 6 months before enrollment (e.g. INF);
研究者
相似试验
已完成
不适用
Response and markers of response in chronic hepatitis B patients treated with peg-interferon alfa-2a and adefovirHepatitis BChronic Hepatitis B Virus (HBV)Infections and InfestationsISRCTN77073364Academic Medical Center (AMC) (The Netherlands)92
尚未招募
不适用
Characterization of intrahepatic immune responses and gene expression profiles in patients with chronic hepatitis Delta10019654Chronic hepatitis Deltaviral liver inflammation10047438NL-OMON56721Erasmus MC, Universitair Medisch Centrum Rotterdam20
Unknown
不适用
Immune Function Status and the Prevalence of Hepatitis in Postpartum Pregnant Women With CHB InfectionChronic Hepatitis BNCT02886182Beijing Ditan Hospital200
终止
4 期
Study of Response in Chronic Hepatitis C (CHC) Participants Genotype 1 With Insulin Resistance and Prolonged Treatment Duration in Late Responders (P04823/MK-4031-303)Hepatitis C, ChronicInsulin ResistanceNCT00493805Merck Sharp & Dohme LLC59
已完成
不适用
Patterns and Outcome of Autoimmune Related Liver DiseaseAutoimmune Liver DiseaseNCT03898414Assiut University50